These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 523403)

  • 1. Muscle relaxant drugs.
    Campbell ED
    Practitioner; 1979 Oct; 223(1336):507-9. PubMed ID: 523403
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of diplacin on spasticity of muscles caused by spinal trauma].
    PARSAMOV SO
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1956; 56(4):326-7. PubMed ID: 13338857
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current data on bipolar disorders, epilepsy and spasticity. 4. Neuro-Forum, Dresden].
    Fortschr Neurol Psychiatr; 1999 May; 67(5 Suppl Aktuelles):1-12. PubMed ID: 10368778
    [No Abstract]   [Full Text] [Related]  

  • 4. [Tolperisone in spasticity and muscle spasm. Tolperisone in multiple sclerosis].
    Nervenarzt; 1996 Jul; 67(7 Suppl Tolperison):1-4. PubMed ID: 9404528
    [No Abstract]   [Full Text] [Related]  

  • 5. Dantrolene sodium in children with spasticity.
    Haslam RH; Walcher JR; Lietman PS; Kallman CH; Mellits ED
    Arch Phys Med Rehabil; 1974 Aug; 55(8):384-8. PubMed ID: 4604292
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative profile of tizanidine in the management of spasticity.
    Lataste X; Emre M; Davis C; Groves L
    Neurology; 1994 Nov; 44(11 Suppl 9):S53-9. PubMed ID: 7970011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Centrally acting skeletal muscle relaxants and associated drugs.
    Waldman HJ
    J Pain Symptom Manage; 1994 Oct; 9(7):434-41. PubMed ID: 7822882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of spastic syndromes].
    Hartmann-von Monakow K
    Bibl Psychiatr Neurol; 1969; 139():114-23. PubMed ID: 4257720
    [No Abstract]   [Full Text] [Related]  

  • 9. Quantification of the effects of muscle relaxant drugs in man by tonic stretch reflex.
    Meyer M; Adorjáni C
    Adv Neurol; 1983; 39():997-1011. PubMed ID: 6660131
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of spasticity in paraplegia. A new muscle relaxant Ciba 34'647-Ba].
    Henning K; Edelmann P
    Med Welt; 1972 Feb; 23(6):203-5. PubMed ID: 5060489
    [No Abstract]   [Full Text] [Related]  

  • 11. Cooperative study for assessing the effects of a pharmacological agent on spasticity.
    Monster AW; Herman R; Meeks S; McHenry J
    Am J Phys Med; 1973 Aug; 52(4):163-88. PubMed ID: 4722384
    [No Abstract]   [Full Text] [Related]  

  • 12. Spasticity and the effect of dantrolene sodium.
    Monster AW
    Arch Phys Med Rehabil; 1974 Aug; 55(8):373-83. PubMed ID: 4605132
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of tizanidine in the treatment of spasticity.
    Neurology; 1994 Nov; 44(11 Suppl 9):S1-80. PubMed ID: 7970005
    [No Abstract]   [Full Text] [Related]  

  • 14. The pharmacotherapy of spinal spasticity: a decade of progress. II. Therapeutics.
    Segatore M; Miller M
    SCI Nurs; 1995 Mar; 12(1):2-7. PubMed ID: 7792578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacologic methods of controlling muscle spasticity].
    Kiwerski J
    Pol Tyg Lek; 1987 Jun; 42(25):776-9. PubMed ID: 3684756
    [No Abstract]   [Full Text] [Related]  

  • 16. Spasticity.
    Behari M
    Neurol India; 2002 Sep; 50(3):235-7. PubMed ID: 12391445
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of Lioresal in spasticity].
    Castaigne P; Held JP; Laplane D; Pierrot-Deseilligny E; Bussel B; Macquart-Moulin J
    Rev Neurol (Paris); 1973 Apr; 128(4):245-50. PubMed ID: 4774911
    [No Abstract]   [Full Text] [Related]  

  • 18. [Mydeton: a centrally acting muscle relaxant drug from Gedeon Richter LTD].
    Kocsis P; Tarnawa I; Kovács G; Szombathelyi Z; Farkas S
    Acta Pharm Hung; 2002; 72(1):49-61. PubMed ID: 12426787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Electromyographic control of the effects of a muscle relaxant: LCB 29 in pyramidal hypertonia].
    Cadilhac J; Daprès G
    Rev Electroencephalogr Neurophysiol Clin; 1972; 2(2):153-8. PubMed ID: 4681591
    [No Abstract]   [Full Text] [Related]  

  • 20. Dantrolene sodium for treatment of spasticity.
    Med Lett Drugs Ther; 1974 Jul; 16(15):61-2. PubMed ID: 4843632
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.